Search Login Register

liraglutide Summary

Description: a 16 carbon fatty acid attached to a lysine in the middle of GLP-1 extends half-life; antidiabetic

Also Known As: NN 2211; NN-2211; NN2211; victoza

Networked: 543 relevant articles (108 outcomes, 144 trials/studies) for this Drug

Key Diseases for which liraglutide is Relevant

  1. Weight Loss (Weight Reduction) : 33 outcomes 30 studies in 147 results
  2. Body Weight (Weight, Body) : 28 outcomes 27 studies in 130 results
  3. Hypoglycemia (Reactive Hypoglycemia) : 11 outcomes 15 studies in 49 results
  4. Weight Gain : 8 outcomes 4 studies in 31 results
  5. Type 2 Diabetes Mellitus (MODY) : 7 outcomes 23 studies in 107 results
Show All >>

Drugs Related to liraglutide

  1. Glucagon-Like Peptide 1 (GLP 1)
  2. Glucose (Dextrose)
  3. exenatide (Byetta)
  4. Insulin (Novolin)
  5. glucagon-like peptide receptor (receptor, glucagon-like peptide)
  6. liraglutide
  7. glimepiride (Amarel)
  8. Hemoglobins (Hemoglobin)
  9. Metformin (Glucophage)
  10. sitagliptin (Januvia)
Show All >>

Therapies Related to liraglutide

  1. Injections
  2. Caloric Restriction
  3. Aftercare (After-Treatment)
  4. Bariatric Surgery
  5. Heterologous Transplantation (Xenotransplantation)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.